Monitor upcoming earnings or pipeline updates for signs of improved operational execution or partnership activity that may result from the leadership change. Absent financial or strategic catalysts, this promotion is a routine internal realignment with limited near-term trading implications.
Price Chart
Executive Summary
Evaxion A/S announced the promotion of Birgitte Rn from Chief Scientific Officer (CSO) to a dual role as CSO and Chief Operating Officer (COO), citing organizational alignment and her long-standing operational and scientific contributions. The move is intended to enhance external engagement and strategy execution around its AI-Immunology platform.
Key Facts
- Birgitte Rn promoted from CSO to joint CSO and COO role at Evaxion A/S
- Promotion follows internal management review aimed at improving external visibility and strategic execution
- No changes to other executive roles; management team remains stable
- No financial terms, compensation changes, or structural reorganization disclosed
- Filing consists solely of a press release with no material financial or operational updates
Financial Impact
No immediate financial impact disclosed
Risk Factors
- Expanded responsibilities without additional team changes could strain leadership capacity
- Lack of external hires or structural changes may limit impact on investor engagement
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-002722 |
| Exhibit: exh_991.htm | 0001171843-26-002722 |
| Document: 0001171843-26-002722-index-headers.html | 0001171843-26-002722 |
| Document: 0001171843-26-002722-index.html | 0001171843-26-002722 |
| Document: 0001171843-26-002722.txt | 0001171843-26-002722 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $3.07 $3.21 | ▲ +4.56% | ▲ +4.45% | $3.21 (+4.63%) |
Sep 4, 2026 28d ago | 6-K | $3.12 $3.07 | ▲ +1.60% | ▲ +0.39% | $3.21 (−2.96%) |
Aug 20, 2026 6w ago | 6-K | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 20, 2026 6w ago | Press Release | $3.28 $3.15 | ▼ −3.96% | ▼ −5.08% | $3.21 (−2.07%) |
Aug 17, 2026 6w ago | 6-K | $3.13 $3.40 | ▲ +8.63% | ▲ +9.82% | $3.21 (+2.63%) |
Aug 14, 2026 7w ago | 6-K | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Aug 14, 2026 7w ago | Press Release | $3.34 $3.31 | ▼ −0.90% | ▲ +0.47% | $3.21 (−3.83%) |
Jul 17, 2026 11w ago | 6-K | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 17, 2026 11w ago | Press Release | $3.08 $3.05 | ▼ −0.81% | ▼ −0.13% | $3.21 (+4.46%) |
Jul 13, 2026 11w ago | 6-K | $3.02 $3.08 | ▲ +1.82% | ▲ +2.61% | $3.21 (+6.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access